Test palonosetron to prevent nausea from chemotherapy
Part of Cancer clinical trials.
This trial studies whether palonosetron helps prevent nausea and vomiting caused by chemotherapy that has a moderate risk of vomiting. It may help you feel more comfortable during chemo and avoid treatment interruptions from severe nausea.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer and are planning to start chemotherapy that commonly causes moderate nausea/vomiting
- Your age is 18 to 75, and your ability to function is fairly good (KPS 70 or higher)
- You are expected to live more than 3 months
- Your heart tracing (ECG), blood counts, and kidney/liver function and electrolytes are mostly normal before starting
- You can sign informed consent, and you are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if two medicines given together, fosaprepitant and palonosetron, can prevent nausea and vomiting caused by strong chemotherapy given over several days. It's for people who have never had chemo before and are about to start a multi-day treatment for a solid tumor.
This study tests two medications (fosrolapitant and palonosetron) to prevent severe nausea and vomiting in patients with esophageal or lung cancer who are receiving chemotherapy combined with immunotherapy. If the medications work well, they could help patients feel better during treatment and complete their cancer care more comfortably.
This study compares two anti-nausea medications, rolapitant and palonosetron, to see how well they prevent nausea and vomiting caused by chemoradiotherapy for lung cancer. It aims to help patients feel more comfortable during treatment.
This trial tests if adding HRS5580 to standard anti-nausea medicine works better to stop vomiting after surgery. You may qualify if you are at moderate-to-high risk for nausea after general anesthesia.
This trial tests a medication called LY3537021 to see if it can prevent nausea and vomiting caused by certain types of chemotherapy (AC or cisplatin) in people who have not had chemo before. It focuses on patients who are otherwise in fairly good health.
This study tests whether the medication NEPA (Netupitant and Palonosetron) can prevent nausea and vomiting in people who have had surgery for liver, gallbladder, or pancreatic cancer. It may help those who want to avoid post-surgery sickness.
Hear when a new Nausea and Vomiting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.